GE HealthCare (GEHC) Stock
Key stats
- Market cap
- $37.35B
- Price / Earnings ratio
- 17.6x
- EPS (TTM)
- $4.74
- Volume
- Loading
- 52-week high
- $89.77
- 52-week low
- $58.75
- Dividend yield
- 0.18%
- Dividend amount (latest)
- $0.04
- EPS vs analyst estimate
- +1.9%Q3 FY25 · $1.07 vs $1.05
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with GEHC
Recent news

GE HealthCare reinforces leadership in AI with Lung Guidance and AutoAS on Vscan Air for point of care ultrasound assessments
GE HealthCare reinforces leadership in AI with Lung Guidance and AutoAS on Vscan Air for point of care ultrasound assessments
GEHC

GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging
GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging
GEHC

GEHC vs. HAE: Which Stock Is the Better Value Option?
GEHC vs. HAE: Which Stock Is the Better Value Option?
GEHC

GE HealthCare Technologies Q3 Earnings Call Highlights
GE HealthCare Technologies Q3 Earnings Call Highlights
GEHC
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 68.69
- MACD 12/26/9
- 4.20
- EMA 9 of MACD
- 3.55
- MACD histogram
- 0.65
- SMA 50
- $70.06
- Price above SMA 50
- EMA 50
- $72.79
- Price above EMA 50
- SMA 200
- $69.90
- Price above SMA 200
- EMA 200
- $72.01
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 8 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $1.26 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

GE HealthCare reinforces leadership in AI with Lung Guidance and AutoAS on Vscan Air for point of care ultrasound assessments
GE HealthCare reinforces leadership in AI with Lung Guidance and AutoAS on Vscan Air for point of care ultrasound assessments
GEHC

GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging
GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imaging
GEHC

GEHC vs. HAE: Which Stock Is the Better Value Option?
GEHC vs. HAE: Which Stock Is the Better Value Option?
GEHC

GE HealthCare Technologies Q3 Earnings Call Highlights
GE HealthCare Technologies Q3 Earnings Call Highlights
GEHC

GEHC Q3 Earnings Beat Estimates on Strong Growth, '26 View Raised
GEHC Q3 Earnings Beat Estimates on Strong Growth, '26 View Raised
GEHC

Compared to Estimates, GE HealthCare (GEHC) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, GE HealthCare (GEHC) Q3 Earnings: A Look at Key Metrics
GEHC

GE HealthCare Stock Eyes Breakout On Best Earnings Since Spinoff
GE HealthCare Stock Eyes Breakout On Best Earnings Since Spinoff
GEHC

GE HealthCare Technologies (GEHC) Q3 Earnings and Revenues Beat Estimates
GE HealthCare Technologies (GEHC) Q3 Earnings and Revenues Beat Estimates
GEHC

GE HealthCare reports third quarter 2026 financial results
GE HealthCare reports third quarter 2026 financial results
GEHC

GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?
GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?
GEHC
News tone: automated (AI) classification of the article's content, not a price prediction.
About GE HealthCare
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Peter J. Arduini | President, CEO & Director | 1965 |
| Ms. Jeannette Bankes | President & CEO of Patient Care Solutions | 1971 |
| Mr. William K. Grogan | Chief Financial Officer | 1979 |
| Dr. Taha Kass-Hout M.D., M.S. | Chief Science & Technology Officer | 1972 |
| Mr. Frank R. Jimenez Esq. | General Counsel & Corporate Secretary | 1965 |
| Mr. George Andrew Newcomb | Controller & Chief Accounting Officer | 1967 |
| Mr. Jahidul H. Khandaker | Chief Information Officer | 1971 |
| Ms. Carolynne Borders | Chief Investor Relations Officer | — |
| Ms. Rana Strellis | Chief Corporate Marketing & Communications Officer | — |
| Mr. Adam Y. Holton | Chief People Officer | 1971 |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 68.69
- MACD 12/26/9
- 4.20
- EMA 9 of MACD
- 3.55
- MACD histogram
- 0.65
- SMA 50
- $70.06
- Price above SMA 50
- EMA 50
- $72.79
- Price above EMA 50
- SMA 200
- $69.90
- Price above SMA 200
- EMA 200
- $72.01
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
8 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $79.00
- Average
- $88.75
- High
- $110.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | +14.9 | +8.6 | +8.9 | -0.6 | -1.6 | +1.8 | -3.3 | -9.3 | -1.7 | -1.9 | +0.3 | +11.4 |
| 2024 | -3.9 | +22.8 | -2.0 | -14.8 | -0.3 | +1.0 | +11.0 | +1.7 | +10.7 | -4.7 | -4.3 | -5.9 |
| 2025 | +12.7 | -0.2 | -6.6 | -11.6 | +4.2 | +5.6 | -6.1 | +5.6 | +4.9 | -0.7 | +7.4 | +3.5 |
| 2026 | -4.6 | +5.2 | -11.2 | -15.5 | +2.1 | +2.1 | +4.9 | +2.2 | -7.2 | +19.7 | +3.8 |



